首页> 外国专利> METHOD FOR PREDICTION OF PAROXYSMAL RISK IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION ACCOMPANIED BY PREVENTIVE ANTIARRHYTHMIC THERAPY

METHOD FOR PREDICTION OF PAROXYSMAL RISK IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION ACCOMPANIED BY PREVENTIVE ANTIARRHYTHMIC THERAPY

机译:预防性心律失常治疗伴有阵发性房颤的患者的阵发性风险预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to cardiology and can be used for prediction of paroxysmal risk of developing atrial fibrillation (AF). Heart rate variability is analyzed in conducting an ECG in a second lead or daily Holter monitoring, at least once every 3 months. Heart rate variability values are SDNN, Rmssd, Delta X, Amo. If SDNN and Rmssd are decreased by 1.9 times, Delta X is decreased 2-fold, Amo is 1.8-fold, a risk of developing atrial fibrillation within first 3 months is predicted.;EFFECT: method enables timely prediction of paroxysmal risk in patients with paroxysmal AF with background of preventive antiarrhythmic therapy, as well as increase the effectiveness of preventive antiarrhythmic therapy by evaluating the complex of the most significant indicators heart rate variability.;1 cl, 3 dwg, 3 tbl
机译:技术领域本发明涉及医学,即心脏病学,并且可以用于预测发生心房颤动(AF)的阵发性风险。至少每3个月进行一次第二次心电图或每日动态心电图监测时进行心电图分析,分析心率变异性。心率变异性值为SDNN,Rmssd,Delta X,Amo。如果SDNN和Rmssd降低1.9倍,Delta X降低2倍,Amo降低1.8倍,则预测在头3个月内发生房颤的风险。具有预防性抗心律不齐治疗背景的阵发性房颤,以及通过评估最重要指标心率变异性的复合物来提高预防性抗心律不齐治疗的有效性。; 1 cl,3 dwg,3 tbl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号